Claims for Patent: 4,752,578

Summary for Patent: 4,752,578

Title:	Collagenase inducing factor
Abstract:	A method for the production of collagenase inducing factor is disclosed which comprises growing the human liver adenocarcinoma cell line SK-HEP-1 in nutrient culture medium at 35.degree.-38.degree. C. and recovering the resulting collagenase inducing factor from the spent cells or conditioned medium.
Inventor(s):	Moore; William M. (St. Charles, MO), Spilburg; Curtis A. (Chesterfield, MO)
Assignee:	Monsanto Company (St. Louis, MO)
Application Number:	06/851,039
Patent Claims:	1. Method for the production of collagenase inducing factor that stimulates synthesis of synovial cell collagenase and prostaglandin E.sub.2 comprising growing the human liver adenocarcinoma cell line SK-HEP-1 in nutrient culture media at 35.degree.-38.degree. C. and recovering the resulting collagenase inducing factor from the spent cells or conditioned medium. 2. The method of claim 1 in which the collagenase inducing factor is recovered from the spent cells by freezing and thawing said cells suspended in low ionic buffer followed by subjecting the resulting cell lysate to the stepwise sequence of chromatofocusing with Polybuffer exchanger, Phenyl-Sepharose chromatography, and Bio-Gel P-30 gel filtration chromatography. 3. The method of claim 1 in which the collagenase inducing factor is recovered from the conditioned medium by the stepwise sequence of ammonium sulfate fractionation, Affi-Gel Blue chromatography, Bio-Gel HTP chromatography, and Sephadex G-75 gel filtration chromatography.

Details for Patent 4,752,578

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2039-03-29